Study S000256

GLP-1 Agonism for Blocking Cocaine Euphoria and Self-Administration

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02302976
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: QUADRUPLE
Status: COMPLETED
Enrollment: 13
Start: 2014-11
Primary completion: 2018-08-01
Lead sponsor: Yale University
Conditions: Cocaine Dependence
Interventions: DRUG:cocaine hydrochloride; DRUG:exenatide; DRUG:placebo
Results posted: FALSE
Secondary identifiers: NIH:1R21DA040914-01A1

Registered primary outcomes

Mean cocaine inter-infusion interval [3 hours]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.